logo
A woman was told she had Alzheimer's 13 years ago. Now she's walking the width of the U.S. after reversing her illness

A woman was told she had Alzheimer's 13 years ago. Now she's walking the width of the U.S. after reversing her illness

Yahoo15 hours ago

Judy Benjamin was only 67 when she was diagnosed with Alzheimer's, the devastating disease her mother and several uncles all suffered from.
The symptoms started slowly; a forgotten phone number, trouble reading the newspaper. But Benjamin soon found reason to panic after a brain scan showed damage and amyloid plaque build-up — hallmarks of Alzheimer's, the progressive neurodegenerative disorder that typically affects memory, thinking, and behavior.
Now 81, Benjamin is in the midst of an epic cross-country walk to prove to herself, and others, that reversal of Alzheimer's symptoms is possible thanks to a specific, science-backed protocol — and she's living proof.
Having started her journey April 5 in San Diego, her hopes to make it to Saint Augustine, Florida, by October 5. She's being accompanied by a support team, and a film crew shooting footage for a documentary. This week she celebrated hitting 1,000 miles.
'I've been really thrilled with the people I've met along the way,' Benjamin told The Independent . 'Everyone knows someone with Alzheimer's and they're very interested in my story because I reversed my cognitive decline by radically changing my life.'
Getting to this point took a series of small steps and big ones as Benjamin navigated her diagnosis. Her symptoms started shortly after her own mother died of the disease 20 years after her initial diagnosis.
"I was working overseas and started to get really worried because I couldn't remember things — even my own phone number or locker combination," she recalled to Fox News Digital. "I got lost driving, when I'm always really good about direction."
Scans of Benjamin's brain showed lots of amyloid plaque — proteins that, when built up on the brain, can result in nerve cell death — and damage to the right and left parietal areas of her brain. Located behind the brain's frontal lobe, the parietal lobe helps with location awareness and processes your sense of touch, according to the Cleveland Clinic.
"I knew that it was going downhill really quickly, and I was extremely depressed and distressed about that,' she said.
In an attempt to chart a new path forward, Benjamin met with Dr. Dale Bredesen at a friend's urging.
Bredesen, an internationally recognized expert in the mechanisms of neurodegenerative diseases and the Chief Science Officer of Apollo Health, had been developing a protocol to reverse the signs and symptoms of Alzheimer's but had yet to test it on a patient. He's long been a believer that Alzheimer's isn't just preventable — it's reversible, too.
So, Benjamin seeking treatment at the time Bredesen was looking for a 'patient zero' was kismet.
Brededsen recalled Benjamin taking 'copious notes' during her first appointment due to her poor memory. He had Benjamin follow his ReCODE (for 'reversal of cognitive decline') protocol, which included changes to Benjamin's diet and exercise routine, as well as making adjustments to her sleep habits and starting meditation.
As Bredesen explained to The Independent about ReCODE: 'The bottom line is that it is a personalized, precision medicine protocol that addresses the drivers specific to each person (so it is based on each person's lab results), and these drivers are in three major groups —energetics (blood flow, oxygenation, etc.), inflammation (from any of many different causes), and toxicity (inorganics, organics, and biotoxins) — and three lesser groups — trophic support (hormones, nutrients, and growth factors), neurotransmitters (such as acetylcholine, which is needed for memory), and stress.'
Bredesen noted, too, that despite published documentation of the ways in which cognitive decline can be reversed, the vast majority of people remain unaware that it is often possible. Treatment is also more likely to be effective if started early on. He's documented his research in several books, including The End of Alzheimer's and The Ageless Brain.
Together, the pair have worked to maintain her progress. She's become a brain health coach and a yoga instructor, and, as Bredesen described her, 'a survivor of cognitive decline, and a remarkable role model for anyone interested in healthy aging.'
'Very very few people are capable of walking 3000 miles, from coast to coast. But to have someone doing it who is 81 years old, and has reversed her cognitive decline after a diagnosis of early Alzheimer's in 2012, is truly historic,' Bredesen told The Independent.
'She is doing something that I could not do, nor could most of the people I know. She is truly an inspiration.'
Still, Benjamin's message is simple — offering the hope that cognitive decline can be prevented and reversed.
'That is really the purpose of my journey,' she told The Independent. 'And also to show that you can be 81 years old and walk all this way one step at a time.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tool Predicts if Seniors with Cancer Can Stay Home Post Op
Tool Predicts if Seniors with Cancer Can Stay Home Post Op

Medscape

time23 minutes ago

  • Medscape

Tool Predicts if Seniors with Cancer Can Stay Home Post Op

TOPLINE: A novel predictive model named STAYHOME effectively estimated the risk of losing the ability to live at home among older adults after cancer surgery, demonstrating good calibration with minimal deviation from observed risks. The model predicted a 2.4% and 3.4% risk for admission to a nursing home at 6 months and 12 months, respectively. METHODOLOGY: Older adults prioritize long-term functional independence, and the ability to return and stay at home after cancer surgery remains a key concern. However, current prognostic tools focus on short-term outcomes, lacking individualized long-term risk estimates. To estimate the risk of losing the ability to live at home post-surgery, researchers developed and internally validated a risk prediction model, named STAYHOME, among 97,353 community-dwelling older adults (median age, 76 years) who underwent cancer surgery between 2007 and 2019. The predictive model included preoperative variables such as age, sex, rural residence, previous cancer diagnosis, surgery type, frailty, receipt of home care support, receipt of neoadjuvant therapy, cancer site, and cancer stage. The primary outcome was the inability to stay at home after cancer surgery, defined as the time to admission to a nursing home, and was measured at 6 months and 12 months. TAKEAWAY: Overall, 2658 patients (2.7%) at 6 months and 3746 (3.8%) at 12 months were admitted to a nursing home post-surgery. The mean predicted risk of not staying home was 2.4% at 6 months and 3.4% at 12 months. The STAYHOME tool demonstrated a strong predictive capability, with areas under the curve of 0.76 and 0.75 for 6- and 12-month predictions, respectively. The tool also demonstrated minimal deviation from the observed risk for 6-month (0.33 percentage point on average; calibration slope, 1.27) and 12-month (0.46 percentage point on average; calibration slope, 1.17) predictions. The model's calibration was excellent for most predictors at 6 months and 12 months, with a deviation of < 0.8 percentage points from the observed probability; only age older than 85 years (1.13%), preoperative frailty (1.16%), and receipt of preoperative home care support (1.25%) exceeded the deviation of 1 percentage point at 12 months. Across risk deciles, deviations between predicted and observed probabilities were 0.1%-1.5% at 6 months and 0.1%-1.9% at 12 months, reflecting good calibration. The deviation for the slight overestimation at or above the seventh decile remained under 2% for both timepoints. IN PRACTICE: 'The STAYHOME tool demonstrated good discrimination and was well calibrated. Thus, it may be a useful tool to identify a specific group of individuals at risk of not remaining home,' the authors wrote. '[The tool] used information readily available to patients, care partners, and healthcare professionals and may be implemented to provide them with individualized risk estimates and improve surgical oncology care delivery and experience for older adults,' they concluded. SOURCE: This study, led by Julie Hallet, MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, was published online in JAMA Surgery. LIMITATIONS: The STAYHOME tool showed slightly reduced discrimination for predictor levels of preoperative frailty, preoperative home care use, receipt of neoadjuvant therapy, and having stage IV disease. The model was also less well calibrated at the extremes of the risk distribution, with a slight overestimation in higher-risk categories. DISCLOSURES: This study was funded by operating grants from the Canadian Institutes for Health Research, Ontario Cancer Research Institute, and ICES. One author reported receiving speaker fees from Ipsen, outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Associated Press

time28 minutes ago

  • Associated Press

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6 —remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. 'Oxygen therapy should be a bridge to more freedom, not more restrictions,' said a VARON CEO. 'That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives.' Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen Solutions Email: [email protected] Website: View original content to download multimedia: SOURCE Varon oxygen concentrator

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Yahoo

time33 minutes ago

  • Yahoo

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6—remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. "Oxygen therapy should be a bridge to more freedom, not more restrictions," said a VARON CEO. "That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives." Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Smart, responsive oxygen delivery Reliable battery solutions and power options Quiet, discreet operation for comfort in public spaces Lightweight builds and ergonomic designs Simple interfaces, suited for users of all ages Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen SolutionsEmail: official@ View original content to download multimedia: SOURCE Varon oxygen concentrator Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store